Ultragenyx Pharmaceutical Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Ultragenyx Pharmaceutical Inc. (RARE) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.170.210.130.310.710.760.46
Short-Term Investments0.440.360.610.430.490.000.00
Cash & Short-Term Investments0.610.580.750.741.200.760.46
Accounts Receivable0.120.070.050.040.030.030.01
Inventory0.050.030.030.020.010.010.01
Other Current Assets0.040.040.070.060.040.040.00
Total Current Assets0.820.730.880.861.300.850.52
Non-Current Assets
Property, Plant & Equipment (Net)0.270.310.290.180.110.070.02
Long-Term Investments0.140.200.150.290.170.000.00
Goodwill0.040.040.040.040.040.000.00
Intangible Assets0.180.170.160.130.130.000.00
Other Non-Current Assets0.060.030.020.020.010.000.00
Total Non-Current Assets0.690.760.660.670.460.280.20
Total Assets1.501.491.551.521.761.140.72
Current Liabilities
Accounts Payable0.040.040.040.020.010.100.07
Short-Term Debt0.010.030.000.000.000.000.00
Current Portion of Long-Term Debt0.050.030.000.000.000.000.00
Accrued Liabilities0.210.200.200.150.110.000.00
Deferred Revenue0.000.000.000.010.060.000.00
Other Current Liabilities0.050.890.010.020.070.010.00
Total Current Liabilities0.340.280.260.180.190.100.07
Non-Current Liabilities
Long-Term Debt0.030.860.880.350.340.030.00
Deferred Tax Liabilities0.030.030.030.030.030.000.00
Other Non-Current Liabilities0.020.010.000.000.000.000.00
Total Non-Current Liabilities0.900.070.060.390.380.060.04
Total Liabilities1.241.221.190.600.610.480.11
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-3.96-3.39-2.78-2.07-1.62-1.43-1.03
Accumulated Other Comprehensive Income0.000.00-0.010.000.000.000.00
Treasury Stock0.000.000.000.000.000.000.00
Additional Paid-in Capital4.213.663.143.002.772.091.64
Minority Interest0.010.000.000.000.000.000.00
Shares Outstanding0.090.080.070.070.000.000.00
Total Stockholders' Equity0.260.280.350.921.150.650.61
Total Liabilities & Equity1.501.491.551.521.761.140.72